J&J-MERCK's U.K. LAUNCH OF OTC FAMOTIDINE (PEPCID AC)
This article was originally published in The Tan Sheet
Executive Summary
J&J-MERCK's U.K. LAUNCH OF OTC FAMOTIDINE (PEPCID AC) began the week of Feb. 14 under the aegis of the joint venture's new Centra Healthcare subsidiary. The consumer launch of the product closely follows the U.K. Medicines Control Agency's Jan. 21 decision to allow the switch from prescription-only status to pharmacy availability of famotidine and 10 other drugs -- including cimetidine (SmithKline Beecham's Tagamet) and beclomethasone dipropionate (Glaxo/Warner-Lambert's Beconase).